Natixis Advisors
ICUI icon

Natixis Advisors’s ICU Medical ICUI Stock Holding History

Natixis Advisors’s Portfolio ICUI Stock Details ICUI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-19,469
Closed -$3.47M – 1507
2023
Q2 		$3.47M Buy
19,469
+407
+2% +$74.7K 0.01% 817
2023
Q1 		$3.14M Buy
19,062
+7,403
+63% +$1.27M 0.01% 821
2022
Q4 		$1.84M Buy
11,659
+960
+9% +$146K 0.01% 970
2022
Q3 		$1.61M Buy
+10,699
New +$1.78M 0.01% 955
2014
Q3 		– Sell
-5,579
Closed -$339K – 1106
2014
Q2 		$339K Buy
5,579
+1,230
+28% +$72.6K ﹤0.01% 1117
2014
Q1 		$260K Buy
4,349
+1,193
+38% +$73.5K ﹤0.01% 1119
2013
Q4 		$201K Buy
+3,156
New +$203K ﹤0.01% 1119

Other funds holding ICUI

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Natixis Advisors's ICUI Position: Q3 2023 in Review

Natixis Advisors sold out of ICU Medical (ICUI) in Q3 2023, closing a stake of 19,469 shares — an estimated $3.47M sold.

Natixis Advisors first reported a position in ICUI in Q4 2013 and held it in 7 quarters. The position peaked at $3.47M in Q2 2023. 220 funds tracked by Wall St. Rank hold ICUI as of Q3 2023.

  • Natixis Advisors reported no remaining ICU Medical position as of Q3 2023 after selling out during the quarter.
  • Natixis Advisors sold 19,469 ICU Medical shares in Q3 2023, an estimated $3.47M.
  • Natixis Advisors first reported a position in ICU Medical in Q4 2013 and held it in 7 quarters.
  • Natixis Advisors's ICU Medical position peaked at $3.47M in Q2 2023.
  • 220 funds tracked by Wall St. Rank held ICU Medical as of Q3 2023.

Based on Natixis Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.